Luminex (LMNX -3.5%) receives a warning letter from the FDA resulting from inspections held at Texas facilities in February, and relates to the Company’s VERIGENE SP instrument and its hybridization heater in connection with FDA requirements.
The Company intends to submit a response within 15 business days.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.